ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Targovax Receives Fast-Track Designation for ONCOS-102 americanpharmaceuticalreview
February 19, 2021Targovax has announced its lead clinical candidate ONCOS-102 has received Fast-Track designation in malignant pleural mesothelioma from the U.S. Food and Drug Administration (FDA).
Pharma Sources Insight January 2025
